247
Views
1
CrossRef citations to date
0
Altmetric
SHORT REPORT

Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study

ORCID Icon, , ORCID Icon, , , , & show all
Pages 661-670 | Received 07 Feb 2023, Accepted 23 May 2023, Published online: 01 Jun 2023

References

  • Bland JM, Altman DG. Regression towards the mean. BMJ. 1994;308(6942):1499. doi:10.1136/bmj.308.6942.1499
  • Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34(1):215–220. doi:10.1093/ije/dyh299
  • Chambless LE, Roeback JR. Methods for assessing difference between groups in change when initial measurement is subject to intra-individual variation. Stat Med. 1993;12(13):1213–1237. doi:10.1002/sim.4780121304
  • Linden A. Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol. 2013;13(1):1. doi:10.1186/1471-2288-13-119
  • Senn S, Brown R. Maximum likelihood estimation of treatment effects for samples subject to regression to the mean. Commun Stat Theory Methods. 1989;18(9):3389–3406. doi:10.1080/03610928908830099
  • Illenberger N, Small DS, Shaw PA. Impact of regression to the mean on the synthetic control method. Epidemiology. 2020;31(6):815–822. doi:10.1097/ede.0000000000001252
  • Lund JL, Richardson DB, Stürmer T. The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep. 2015;2(4):221–228. doi:10.1007/s40471-015-0053-5
  • McGrath L, Nielson C, Saul B, et al. Lessons learned using real-world data to emulate randomized trials-a case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther. 2021;110(6):1570–1578. doi:10.1002/cpt.2399
  • Brookhart MA. Counterpoint: the treatment decision design. Am J Epidemiol. 2015;182(10):840–845. doi:10.1093/aje/kwv214
  • Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available: table 1. Am J Epidemiol. 2016;183(8):758–764. doi:10.1093/aje/kwv254
  • Stürmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275(6):570–580. doi:10.1111/joim.12197
  • Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, Stürmer T. Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research. Gastrointest Endosc. 2019;90(3):360–369. doi:10.1016/j.gie.2019.04.236
  • Brookhart MA, Wyss R, Layton JB, Stürmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604–611. doi:10.1161/CIRCOUTCOMES.113.000359
  • Morris TP, White IR, Crowther MJ. Using simulation studies to evaluate statistical methods. Stat Med. 2019;38(11):2074–2102. doi:10.1002/sim.8086
  • Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156. doi:10.1093/aje/kwj149